Cargando…
Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
Gonadotropin-releasing hormone analogues (GnRHa) are recommended as initial treatment for adolescents diagnosed with gender dysphoria, providing time to follow gender identity development and consider further treatment wishes without distress caused by unwanted pubertal changes. This has been descri...
Autores principales: | Brik, Tessa, Vrouenraets, Lieke J. J. J., de Vries, Martine C., Hannema, Sabine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497424/ https://www.ncbi.nlm.nih.gov/pubmed/32152785 http://dx.doi.org/10.1007/s10508-020-01660-8 |
Ejemplares similares
-
Incidence of Idiopathic Intracranial Hypertension in Individuals With Gonadotropin-Releasing Hormone Analogue Treatment for Gender Dysphoria in Sweden
por: Karamanis, Georgios, et al.
Publicado: (2023) -
Perceptions of Sex, Gender, and Puberty Suppression: A Qualitative Analysis of Transgender Youth
por: Vrouenraets, Lieke Josephina Jeanne Johanna, et al.
Publicado: (2016) -
Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents
por: Nos, Andrea L., et al.
Publicado: (2022) -
Perceptions on the function of puberty suppression of transgender adolescents who continued or discontinued treatment, their parents, and clinicians
por: Vrouenraets, Lieke J.J.J., et al.
Publicado: (2021) -
Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones
por: Schagen, Sebastian E E, et al.
Publicado: (2020)